Eli Lillys NextGeneration Obesity Drug Retatrutide Passes Pivotal Trial Moves Toward Regulatory Filing SpaceX IPO Filing Analysis Released by KraneShares AGIX ETF Highlighted for PreIPO Exposure POET Technologies Expands Operational Footprint Shares Surge 13 Novartis Raises Annual Outlook Signaling Confidence in Growth Trajectory Indian Equity Benchmarks Extend Gains for Third Session on Banking Financial and Auto Buying Japan Core Inflation Dips to Over FourYear Low Potentially Easing Pressure for BOJ Rate Hike Envela Corporation ELA Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock EQBK Q1 2026 Earnings EPS Misses Estimates as Earnings Face Headwinds Sensata Technologies ST Q1 2026 Earnings Slight EPS Beat as Management Highlights Operational Discipline TXNM Q1 2026 Earnings EPS Miss of 314 Disappoints Stock Edges Lower HGTY Q1 2026 Earnings Narrowly Beats EPS Estimates Stock Edges Higher ADI Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Demand Antalpha Platform Holding Faces Resistance After 22 Decline BRP Inc DOO Edges Higher to 5538 as Shares Test Key Levels ESAB Corporation ESAB Gains 294 as Technical Levels Come into Focus Black Hawk Acquisition Corporation Units BKHAU Price Steady at 1190 as SPAC Market Scrutiny Continues AFGE American Financial Group 4500 Subordinated Debentures due 2060 Holds Steady Amid FixedIncome Calm Chinas Robotics Push Poses Competitive Challenge for Global Players Musk Says Westrock Coffee Q1 2026 Earnings EPS Misses Estimates as Losses Widen Stock Slips Babcock Wilcox Notes BWNB Edge Higher in Quiet Trading Key Levels in Focus Fennec Pharmaceuticals FENC Holds Steady Near Support as Investors Assess Outlook Globant GLOB Faces Selling Pressure as Shares Decline Over 3 Drugs Made In America Acquisition Corp Rights DMAAR Edges Higher Analyzing the 012 Level NAPCO Security Technologies NSSC Edges Lower Amid Consolidation Near Support Hologic Inc HOLX Holds Steady at 7601 as Traders Eye Key 7981 Ceiling Flowco Holdings FLOC Slides Slightly Maintains Position Above Critical Support PDS Biotechnology PDSB Rises 345 as Stock Holds Above Key Support Level